Monkeypox virus containment: the application of ring vaccination and possible challenges

Thumbnail
Date
2022
Author(s)
Sah, R.
Abdelaal, A.
Asija, A.
Basnyat, S.
Sedhai, Y.R.
Ghimire, S.
Sah, S.
Katterine Bonilla-Aldana, D.
Rodriguez-Morales, A.J.
Metadata
Show full item record
Abstract
Monkeypox virus (MPXV), which resulted in sporadic outbreaks in the past, has recently re-emerged, reaching an alarming stage at a global level. Up to 5 July 2022, 6924 confirmed cases have been reported in 52 countries.1 Due to its pandemic potential, efforts should be directed towards its proper containment in a timely manner. Effective vaccination plays a critical role in this regard. Two FDA-licenced vaccines for smallpox have shown efficacy in providing cross-protection against MPXV...
URI
https://hdl.handle.net/20.500.12805/4750
DOI
https://doi.org/10.1093/jtm/taac085
Collections
Subject
https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2